MACROGENICS INC 8-K

What Happened

• MacroGenics, Inc. (MGNX) filed an Form 8‑K reporting that Jay Siegel, M.D., informed the company on February 25, 2026 that he will not stand for re‑election as a Class I director at the Company’s 2026 Annual Meeting of Stockholders. The filing was submitted on March 2, 2026.
• The filing states Dr. Siegel’s decision is for personal reasons and is not the result of any disagreement with the company or any matter relating to its operations, policies or practices. The company thanked Dr. Siegel for his contributions.

Key Details

• Director: Jay Siegel, M.D.; Position: Class I director.
• Notice date to the board: February 25, 2026; 8‑K filing date: March 2, 2026.
• Reason given: personal reasons; explicitly not due to any disagreement with the company.
• Company action: public acknowledgement and thanks; no replacement or other board changes disclosed in this filing.

Why It Matters

• Board composition change: Investors should note a vacancy or forthcoming nomination at the 2026 annual meeting, which could affect governance or committee membership depending on who is nominated/replaces him.
• No operational concerns disclosed: The company said the departure was personal and not related to disagreements or company practices, which limits immediate governance red flags.
• Watch for follow-ups: Monitor upcoming proxy materials or subsequent filings for details on any nominee, timetable for replacement, or changes to board committees.